← FDA DRUG APPROVALS

FDA ANDA · ANDA075565

LORATADINE

Sponsor: PHARM ASSOC

APPLICATION
ANDA075565
TYPE
ANDA
ORIGINAL APPROVAL
2004-10-05
LATEST ACTION
2004-10-05
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued, Over-the-counter

Products

LORATADINEDiscontinued
LORATADINE 1MG/ML · SYRUP · ORAL
LORATADINEOver-the-counter
LORATADINE 5MG/5ML · SYRUP · ORAL

Approval history

2004-10-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →